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ABSTRACT 20 
Chitosan/carrageenan/tripolyphosphate nanoparticles were prepared by polyelectrolyte 21 
complexation/ ionic gelation, the latter compound acting as cross-linker. The 22 
incorporation of the three components in the nanoparticle matrix was assessed by 23 
analytical techniques (FTIR, XPS and TOF-SIMS). 24 
Using chitosan/carrageenan nanoparticles as control, the effect of the cross-linker in the 25 
particles properties was studied. A decrease in size (from 450-500 nm to 150-300 nm) 26 
and in zeta potential (from +75 - +85 mV to +50 - +60 mV), and an increase in 27 
production yield (from 15-20% to 25-35%), and in stability (from one week to up to 9 28 
months) were observed. Also, a correlation between positive to negative charge ratios in 29 
the formulations and the above characteristics was established.  30 
The small size and high positive surface charge make the developed 31 
chitosan/carrageenan/tripolyphosphate nanoparticles potential tools for an application in 32 
mucosal delivery of macromolecules.  33 
 34 
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1. Introduction 37 
Polymeric nanoparticles have been used increasingly in various fields, such as drug 38 
delivery, imaging and tissue engineering, the first being, by far, the most reported 39 
application. The main reason justifying the widespread use of polymeric nanoparticles 40 
relies on the displayed high surface-to-volume ratio which improves the loading 41 
capacity of the selected molecule, while providing its protection. In addition, increased 42 
drug absorption might be attained by the capacity of nanoparticles to reduce epithelial 43 
resistance to transport (de la Fuente, Csaba, Garcia-Fuentes & Alonso, 2008; Rawat, 44 
Singh & Saraf, 2006; Reis & Ribeiro, 2006). 45 
Many polymers have been used to prepare these vehicles, but those of natural origin are 46 
often preferred because, as compared to synthetic counterparts, they comply more easily 47 
with the requisites of biocompatibility, biodegradability and absence of toxicity that are 48 
mandatory in any biomedical application (Liu, Jiao, Wang, Zhou & Zhang, 2008; 49 
Malafaya, Silva & Reis, 2007). Chitosan (CS) and carrageenan (CRG) are two marine-50 
derived polymers which belong to the above mentioned class, and have demonstrated in 51 
a previous study the ability to assemble into nanoparticles of 400-600 nm (Grenha et al., 52 
2010). CS is a cationic polysaccharide composed of repeating units of N-53 
acetylglucosamine and D-glucosamine that are β-(1-4)-linked (Figure 1), and presents 54 
well-documented favorable properties for drug delivery such as biocompatibility, 55 
biodegradability, low toxicity (Dornish, Hagen, Hansson, Peucheur, Vedier & 56 
Skaugrud, 1997; Hirano, Seino, Akiyama & Nonaka, 1988) and mucoadhesiveness 57 
(Lehr, Bouwstra, Schacht & Junginger, 1992). CRG is another polysaccharide, extracted 58 
from red seaweed (van de Velde, Knutsen, Usov, Rollemay & Cerezo, 2002) and 59 
composed of galactose and anhydrogalactose units, linked by glycosidic bonds (Figure 60 
1) (Lim, Gwon, Choi, Shin & Nho, 2010). Due to its half-ester sulfate moieties, 61 
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carrageenan displays a strong ionic nature and exhibits a high capacity to react with 62 
proteins (Malafaya, Silva & Reis, 2007; Mohamadnia, Zohuriaan-Mehr, Kabiri, 63 
Jamshidi & Mobedi, 2007). There are two types of carrageenan that evidence gel-64 
forming ability, k- and i-, k-carrageenan gels being more firm than those obtained with i-65 
carrageenan, which are more elastic and soft (Bixler, 1993). The assembly of the 66 
referred CS/CRG nanoparticles was mediated by polyelectrolyte complexation (Grenha 67 
et al., 2010), a method that uses very mild conditions, avoiding harmful organic solvents 68 
or high shear forces. Therefore, it has the general capability of protecting the 69 
encapsulated molecules and retaining their activity during the encapsulation, which are 70 
its principal advantages (Mohanraj & Chen, 2006; Saboktakin, Tabatabaie, Maharramov 71 
& Ramazanov, 2010; Grenha, 2012). This methodology involves the interaction 72 
between a chitosan with high degree of protonation and a polyanion, permitting the 73 
rapid formation of nanoparticles. Their size, as well as other characteristics, might be 74 
modulated by adjusting formulation parameters like the type of materials composing the 75 
particles matrix, their concentration and mass ratios, amongst others (Calvo et al. 1997a; 76 
Grenha, 2012). 77 
In many cases, for instance if the nanoparticles are to be applied in mucosal delivery, it 78 
is important to ensure that their size will permit the contact with the epithelial surface, 79 
an effect that is maximised for particles between 50 and 500 nm (Desai, Labhasetwar, 80 
Amidon & Levy, 1996; Jani, Halbert, Langridge & Florence, 1990). Preparing 81 
nanoparticles in this size range is facilitated by the use of adequate cross-linking agents. 82 
Tripolyphosphate (TPP) is a non-toxic polyanion (Figure 1) known for its capacity to 83 
cross-link chitosan, a reaction mediated by electrostatic forces, resulting in the 84 
formation of ionic cross-linked networks (Janes, Calvo & Alonso, 2001; Mi, Sung, 85 
Shyu, Su & Peng, 2003). 86 
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The objective of this work was to produce CS/CRG nanoparticles, including in the 87 
formulation TPP as cross-linking agent, and to evaluate the effect of the presence of this 88 
polyanion on the properties of nanoparticles, namely concerning size, surface charge 89 
and stability. To do so, different amounts of cross-linker were used and formulations 90 
with different polymeric mass ratios were tested. Reduced size and strong positive 91 
surface charge would improve the nanoparticles contact with mucosal epithelial 92 
surfaces, which is very positive when considering an application in mucosal drug 93 
delivery.  94 
 95 
2. Experimental 96 
2.1.  Materials 97 
Chitosan (low molecular weight, deacetylation degree = 75-85%), pentasodium 98 
tripolyphosphate, glycerol and glacial acetic acid were supplied by Sigma Chemicals 99 
(Germany). k-carrageenan and potassium bromide (KBr) were obtained from FMC 100 
Biopolymer (Norway) and Riedel-del-Haën (Germany), respectively. Ultrapure water 101 
(Milli-Q Plus, Millipore Iberica, Spain) was used throughout. 102 
 103 
2.2.  Nanoparticles preparation 104 
CS/CRG/TPP nanoparticles were prepared by a modification of a previously 105 
described methodology (Grenha et al., 2010), based on the polyelectrolyte complexation 106 
of CS with CRG and additional ionic gelation of chitosan with TPP anions. Briefly, CS 107 
was dissolved in 1% (w/w) acetic acid to obtain a solution of 1 mg/mL and CRG and 108 
TPP were dissolved in purified water to obtain stock solutions of 2.5 and 1.0 mg/mL, 109 
respectively. Different volumes of the latter solutions were mixed in order to obtain 110 
volumes of 0.8 mL of solutions with the required concentrations of both components. 111 
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The spontaneous formation of nanoparticles occurs upon incorporation, under gentle 112 
magnetic stirring at room temperature, of the aforementioned solutions into 2 mL of the 113 
CS solution, corresponding to final theoretical CS/CRG/TPP ratios varying from 4/1/0 114 
to 7/1/1 (w/w). 115 
Nanoparticles were concentrated by centrifugation at 16 000 x g on a 10 µL glycerol 116 
layer for 30 min at 15 °C (centrifuge 5804R, Eppendorf, Germany). The supernatants 117 
were discarded and nanoparticles were ressuspended in 200 µL of purified water. 118 
 119 
2.3.  Nanoparticles physicochemical characterization 120 
The production yield of nanoparticles was calculated by gravimetry. Fixed volumes 121 
of nanoparticle suspensions were centrifuged (16 000 x g, 30 min, 15 °C), and 122 
sediments were freeze-dried over 24 h at -34 °C, followed by a gradual increase in 123 
temperature until 20 °C, using a Labconco freeze dryer (Labconco, USA) (n = 3). 124 
The process yield (P.Y.) was calculated as follows: P.Y. (%) = (nanoparticle 125 
sediment weight/total solid weight) x 100. 126 
The morphological examination of CS/CRG/TPP nanoparticles was conducted by 127 
transmission electron microscopy (TEM) (JEM-1011, JEOL, Japan). The samples were 128 
stained with 2% (w/v) phosphotungstic acid and placed on copper grids with Formvar® 129 
films for TEM observation. 130 
Measurements of nanoparticle size and zeta potential were performed on freshly 131 
prepared samples by photon correlation spectroscopy and laser Doppler anemometry, 132 
respectively, using a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). For the 133 
analysis of particle size and determination of the electrophoretic mobility, each sample 134 
was diluted to the appropriate concentration with ultrapure water and placed in the 135 
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electrophoretic cell. Each analysis was performed at 25 °C. Three batches of each 136 
formulation were analyzed (n = 3). 137 
 138 
2.4.  Nanoparticle stability study  139 
Aliquots of nanoparticle formulations with and without TPP (formulations 5/1/1 and 140 
5/1/0, respectively) were stored at 4 ºC. Nanoparticle sizes and zeta potentials were 141 
monitored as a function of time for 250 days, using the technique described above (n = 142 
3).  143 
 144 
2.5.  Nanoparticles chemical analysis 145 
2.5.1. Fourier transform infrared (FTIR) spectroscopy 146 
The interactions between the different components of the nanoparticulate systems 147 
were analyzed by FTIR. Infrared spectra of the specimen powders, namely CS, CRG 148 
and TPP, and CS/CRG/TPP nanoparticles (formulation 5/1/1), were recorded using a 149 
FTIR spectrophotometer (Tensor 27, Bruker, Germany). Prior to the assay, the samples 150 
were gently triturated with KBr and compressed into discs. 151 
For each spectrum a 32-scan interferogram was collected in transmittance mode with 152 
a 4 cm-1 resolution in the 4000–400 cm-1 region at room temperature. 153 
 154 
2.5.2. Surface analysis by X-Ray photoelectron spectroscopy (XPS) and time-of-155 
flight secondary ion mass spectrometry (TOF-SIMS)  156 
The surface of CS/CRG/TPP nanoparticles was analyzed to determine their chemical 157 
composition. To do so, a droplet of nanoparticles (formulations 4/1/1 and 5/1/1) was 158 
placed directly on a polished monocrystalline silicon wafer, used as a sample holder. 159 
The droplet was then allowed to dry in a desiccator, prior to the analyses. The surface of 160 
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the samples was analyzed by XPS (K-Alpha ESCA, Thermo Scientific, UK) and TOF-161 
SIMS (TOF-SIMS IV, Ion-TOF GmbH, Germany). Solutions of the different 162 
compounds (CS, CRG and TPP) were analysed separately as controls. 163 
The XPS measurements were carried out using monochromatic Al-Ka radiation (hv = 164 
1486.6 eV), and photoelectrons were collected from a take-off angle of 90° relative to 165 
the sample surface. The X-Ray monochromatic spots were 400 µm in diameter and the 166 
correspondingly sampling area was 0.1256 mm2. Measurements were performed in 167 
constant analyzer energy (CAE) mode with 100 eV pass energy for survey spectra and 168 
20 eV pass energy for high-resolution spectra. Charge referencing was done by setting 169 
the lower binding energy C 1s photopeak at 285.0 eV, the C 1s hydrocarbon peak 170 
(Briggs & Seah, 1983). Surface elemental composition was determined using the 171 
standard Scofield photoemission cross section. Residual vacuum in the analysis 172 
chamber was maintained at around 3 x 10-9 mbar. 173 
For TOF-SIMS analyses, samples were bombarded with a pulsed bismuth ion beam 174 
(Bi3+) generated with a liquid metal ion gun operated at 25 keV and a 45° incidence 175 
with respect to the sample surface. The secondary ions generated were extracted with a 176 
10 kV voltage, and their time-of-flight from the sample to the detector was measured in 177 
a reflectron mass spectrometer. Electron flood gun charge compensation was necessary 178 
during measurements. A raster size of 500 µm × 500 µm was used, and at least three 179 
different spots were analyzed under the “static” condition with ion doses of 2 x 1012 180 
ions/cm2. The calibration of the mass spectra in the positive mode was based on 181 
hydrocarbon peaks such as CH3+, C2H3+, C3H5+ and C7H7+. Negative spectra were 182 
calibrated to the C-, C2-, C3-, C4-, C2H-, C3H- and C4H- peaks before further analysis. The 183 
experimental conditions (ion type, beam voltage, and primary ion dose) were 184 
maintained constant for each experiment. 185 
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 186 
2.6. Statistical analysis 187 
The t-test and the one-way analysis of variance (ANOVA) with the pair wise 188 
multiple comparison procedures (Student-Newman-Kleus Method) were performed to 189 
compare two or multiple groups, respectively. All analyses were run using the 190 
SigmaStat statistical program (Version 3.5, SyStat, USA) and differences were 191 
considered to be significant at a level of p < 0.05. 192 
 193 
3. Results and discussion 194 
3.1.  CS/CRG/TPP nanoparticles characterization 195 
CS/CRG/TPP nanoparticles were produced by a very mild polyelectrolyte 196 
complexation/ionic gelation method, as described in the Experimental Section. Briefly, 197 
when the three components are mixed, an electrostatic interaction is established between 198 
the positively charged amino groups of CS and the negatively charged sulphate and 199 
phosphate groups of CRG and TPP, respectively, leading to the nanoparticle formation 200 
in a process derived from inter- and intramolecular linkages mediated by the anionic 201 
molecules (Janes, Calvo & Alonso, 2001). TPP affords a further intense interaction, as it 202 
provides a cross-linking effect. Figure 2 displays a TEM microphotograph of 203 
representative CS/CRG/TPP nanoparticles, showing a spherical morphology and 204 
compact structure. 205 
An estimation of the positive to negative (+/-) charge ratios for the different 206 
formulations was made, based on the following assumptions: 1) Chitosan was 207 
considered to have one positive charge per deacetylated monomer and, since it has a 208 
deacetylation degree of 75-85%, a mean value of 0.8 positive charges per monomer was 209 
used. According to a reported method (Ma et al, 2008) an average monomeric molecular 210 
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weight of 169 g/mol for this deacetylation degree was obtained; 2) Carrageenan was 211 
assumed to be in the sodium salt form, to which corresponds a mass of 408 g/mol and a 212 
negative charge per disaccharide monomer unit; 3) Pentasodium tripolyphosphate has a 213 
molar mass of 368 g/mol and five negative charges per anion. The mass of each 214 
compound in every formulation was then converted to moles of charge and the +/- 215 
molar ratio was calculated. 216 
As can be seen in Figure 3, formulations with mass ratios below 4/1/1 (as 2/1/0.5 and 217 
3/1/1), which evidence a +/- charge ratio around 1 (Figure 3A), resulted in precipitation 218 
(Figure 3B). The observed precipitation for lower ratios is due to the presence of an 219 
excess of anionic charges, which neutralize chitosan positive charges and, thus, reduce 220 
or eliminate electrostatic repulsion, leading to precipitation. In fact, a 1:1 +/- charge 221 
stoichiometry does not mean that complete charge neutralization will occur, due to 222 
different charge spacings in the intervenient species and to steric constraints. However, 223 
one may assume a preferential interaction between the sulphate and the ammonium 224 
groups, both weakly hydrated, instead of with the strongly hydrated counterions 225 
(Crouzier & Picart, 2009). The same assumption should apply to TPP polyanion. This 226 
would lead to mainly an intrinsic charge matching in detriment of an extrinsic charge 227 
compensation and, thus, to a small deviation from neutrality. 228 
On the contrary, the formulation corresponding to a mass ratio of 7/1/0, which 229 
displays a +/- charge ratio of 13.5, did not lead to nanoparticle formation. As observed 230 
by other authors and, according to the described formation mechanism of nanoparticles, 231 
which is mediated by electrostatic interactions, the absence of nanoparticle formation is 232 
attributed to an insufficient number of anionic charges to neutralise CS amino groups 233 
(Calvo, Remuñán-López, Vila-Jato & Alonso, 1997a; Fernández-Urrusuno, Calvo, 234 
Remuñán-López, Vila-Jato & José Alonso, 1999). For this reason, Figure 4 only depicts 235 
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the physicochemical characteristics of CS/CRG/TPP nanoparticles of mass ratios 236 
between 4/1/0 and 6/1/1. 237 
Observing in Figure 4A the data corresponding to formulations containing only 238 
CS/CRG (4/1/0 to 6/1/0), no significant differences are observed for both size and zeta 239 
potential, which lay around 450-500 nm and +80 mV, respectively. However, bearing in 240 
mind the observations of Figure 3A, concerning charge ratios, there is a tendency to 241 
decrease the size from the formulation 4/1/0 (charge ratio of 7.7) to 6/1/0 (charge ratio 242 
of 11.6), which is attributed to the increase in the charge ratio, as reported elsewhere 243 
(Chen, Mohanraj, Wang & Benson, 2007; Nizri, Magdassi, Schmidt, Cohen & Talmon, 244 
2004; Nizri, Makarsky, Magdassi & Talmon, 2009). Increasing CRG content in the 245 
formulation (from 6/1/0 to 4/1/0) leads to a lower charge ratio due to the negative 246 
charge of CRG sulphate groups. This resulted, as expected, in a zeta potential decrease. 247 
Comparing these data with some reported previously for CS/CRG nanoparticles 248 
(Grenha et al., 2010), we observe similar tendencies but smaller nanoparticle sizes in the 249 
present work for comparable formulations, which might be explained by the use of 250 
chitosan and carrageenan from different suppliers (van de Velde, Knutsen, Usov, 251 
Rollemay & Cerezo, 2002). In Figure 4B it is seen that the production yields are 252 
relatively low (13-19%) and comparable in all cases. In the present study, CS/CRG 253 
nanoparticles were used as control.  254 
The incorporation of TPP in the matrix of nanoparticles succeeded in providing an 255 
effective cross-linking effect. More specifically, the presence of TPP resulted in 256 
alterations on all the typical characterization parameters, namely the nanoparticle size 257 
and zeta potential (Figure 4A), as well as production yield (Figure 4B). For the highest 258 
amount of TPP incorporated (mass ratio of 1 compared to chitosan), particle size 259 
decreased to 176-208 nm (p < 0.05) and zeta potential also decreased from  +80 mV to 260 
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approximately +50 mV (p < 0.05). Size decrease is attributed to the cross-linking effect, 261 
which induces the condensation of polymeric chains, resulting in smaller particles. The 262 
simultaneous decrease in zeta potential is a consequence, not only of the inclusion of a 263 
negatively charged material in the matrix of nanoparticles, but also of the general size 264 
decrease, which possibly exposes a lower number of charged groups because of the 265 
diminished surface. Interestingly, it can be observed that the incorporation of a mass 266 
ratio of only 0.5 of TPP is enough to induce a clear effect on size and zeta potential, but 267 
a higher amount of cross-linking agent (mass ratio of 1 compared to chitosan) is 268 
necessary to produce a significant effect on production yield (p < 0.05). In fact, if the 269 
formulation 4/1 is considered as example, it is seen by observation of Figure 4 that the 270 
addition of 0.5 TPP does not modify the production yield, but it significantly decreases 271 
both the nanoparticles size, by 45% (from 491 nm to 269 nm), and the zeta potential, by 272 
25% (from +78 to +54 mV). A further increase of 0.5 TPP, resulting in a final 273 
CS/CRG/TPP = 4/1/1, results in a significant increase of the production yield to 36%, 274 
while the changes in the size and zeta potential, although significant (p < 0.05), are not 275 
very pronounced, as size decreases 61 nm and zeta potential 4 mV. This trend was 276 
similarly observed for the remaining formulations and, in all cases, the polydispersity 277 
index was lower than 0.3. The inclusion of TPP in the nanoparticles was also observed 278 
to result in unimodal size distribution. 279 
The production yield practically doubled in all formulations with the highest amount 280 
of TPP (p < 0.05), reaching a maximum of 36% for CS/CRG/TPP = 4/1/1. This 281 
behaviour could be explained by the specific mechanism of nanoparticle formation, 282 
according to which a determined amount of negative charges is necessary to provide a 283 
certain degree of neutralisation of chitosan amino groups, which leads to the formation 284 
of nanoparticles. When adding 0.5 TPP the cross-linking occurs, decreasing the size of 285 
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nanoparticles, but the amount of phosphate groups is not enough to increase the number 286 
of formed nanoparticles, an effect that is observed when TPP amount is doubled. The 287 
obtained results are in accordance with the ability of TPP to cross-link chitosan, 288 
demonstrating in this case the capacity to decrease the size of chitosan-based 289 
nanoparticles obtained by polyelectrolyte complexation with another polymer.  290 
These results demonstrate, as a whole, that the charge ratio plays a critical role in the 291 
production of nanoparticles by electrostatic interactions. In fact, it is shown that the 292 
final properties of CS/CRG/TPP nanoparticles can be adjusted by modulating charge 293 
ratios. 294 
 295 
3.2. Nanoparticles stability study 296 
The data corresponding to nanoparticles size evolution over time is depicted in 297 
Figure 5, for formulation CS/CRG/TPP = 5/1/1 and for the corresponding CS/CRG 298 
formulation, which was used as control. The rationale of conducting this assay in water 299 
was the interest in obtaining information on the nanoparticles stability in the 300 
resuspension medium. In the cases where the nanoparticles are an intermediate product 301 
of the final drug delivery system, as reported in some works of our group (Grenha, 302 
Seijo, Serra & Remuñán-López, 2007; Al-Qadi, Grenha & Remuñán-López, 2011), this 303 
could avoid the need of extra procedures to stabilize the nanoparticles, as a 304 
lyophilization step for instance. 305 
The formulation without TPP tends to demonstrate some degree of size variation, 306 
although not statistically significant, accompanied by an increase in the polydispersity 307 
after 7 days of storage. On the contrary, the formulation containing TPP evidenced 308 
improved stability, without signals of significant size variation during the experimental 309 
period of 250 days. Zeta potential was also monitored in this study, but no alterations 310 
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were found over time for either of the assayed formulations (data not shown). Other 311 
authors reported the stability of CS/TPP nanoparticles when stored at 5 ºC for 15 days 312 
in non-buffered medium, further observing an increase in the polydispersity after that 313 
period, as the standard deviation of mean size of the nanoparticles registered a 314 
significant increase (López-León, Carvalho, Seijo, Ortega-Vinuesa & Bastos-González, 315 
2005). The results found in the present study for the CS/CRG/TPP formulation indicate 316 
that TPP acts as a stabiliser, possibly because of its cross-linking effect, which causes 317 
polymeric molecules to establish stronger interactions with each other to form a more 318 
stable structure, less prone to aggregation. Actually, cross-linking reactions have been 319 
described to improve the properties of particulates (Mi, Sung, Shyu, Su & Peng, 2003), 320 
hydrogels (Sung, Huang, Chang, Huang & Hsu, 1999) and scaffolds (Adekogbe & 321 
Ghanem, 2005), amongst other structures.  322 
 323 
3.3. Chemical analysis of nanoparticles 324 
As commented above, formulations containing TPP showed different 325 
physicochemical characteristic as compared to those without TPP, which suggests that 326 
TPP is in fact incorporated in the matrix of nanoparticles. Nevertheless, an indubitable 327 
demonstration of TPP presence is possible only by chemical analysis of the 328 
formulations. In this manner, specific techniques of chemical analysis, such as FTIR, 329 
XPS and TOF-SIMS, were used to characterize the chemical composition of 330 
nanoparticles, the last two techniques referring to surface analysis. 331 
 332 
3.3.1. FTIR analysis 333 
The FTIR spectrum of CS/CRG/TPP nanoparticles is depicted in Figure 6, along with 334 
the spectra of all the materials separately (CS, CRG and TPP), which were used as 335 
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controls in this assay. TPP spectrum presents two intense absorption bands at 1147 and 336 
906 cm-1, attributed, respectively, to P=O and P-O along with P-O-P. The overlapping 337 
of the former with the sulphate band of k-carrageenan (van de Velde, Knutsen, Usov, 338 
Rollemay & Cerezo, 2002) and of the latter with the carbohydrate bands, renders the 339 
detection of their presence in the nanoparticles ambiguous. Moreover, those bands are 340 
expected to shift upon protonation and hydrogen bonding (Jiang, Saxena, Song, Ward, 341 
Beveridge & Myneni, 2004), which may occur during particle formation. However, the 342 
collapse of the sulphate and polysaccharide bands observed in the nanoparticles may be 343 
accounted for if TPP is present, especially if shifting of the 1147 cm-1 band occurred. 344 
Also, the band at 894 cm-1 in the nanoparticles may be attributed to a shift in the 906 345 
cm-1 band of TPP. The amide bands are masked by the 1644 cm-1 bending band  346 
of adsorbed water (Wilson, Smith, Kacurakova, Saunders, Wellner & Waldron, 2000) 347 
and the new 1539 cm-1 absorption of the amino groups in protonated CS. 348 
 349 
3.3.2. Surface analysis by XPS and TOF-SIMS 350 
XPS is one of the most commonly used techniques of surface analysis. Upon 351 
exposure of the sample to an X-ray beam, the binding energies of characteristically 352 
emitted photoelectrons are measured, providing information on the elements from 353 
which they originate, as well as their chemical bonding. Table 1 displays the percentage 354 
of each chemical element present in the sample of either controls (CS, CRG and TPP) 355 
or nanoparticles. The final chemical composition of a sample can be obtained from core 356 
photoemission intensity peak areas using the Shirley background subtraction technique 357 
from the survey spectra. The element composition can be quantified by using X-ray 358 
photoelectron intensity values and the Scofield theoretically derived set of atomic 359 
sensitivity factors. Some of the samples showed an intensive silicon signal (data not 360 
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shown), which is attributed to the substrate, as a consequence of an incomplete coating 361 
of the substrate surface with the sample. These Si signals do not compromise the 362 
obtained results and are not included in Table 1. The survey of controls detected the 363 
expected elements, such as carbon (C), oxigen (O), nitrogen (N), phosphorus (P) and 364 
sulfur (S). The obtained CS composition (64.1% C, 29.6% O and 6.3% N) is similar to 365 
that observed by Silva et al., who used the same CS type to produce membranes and 366 
obtained 66.4% C, 28.0% O and 5.6% N. In addition, these authors report an O/N ratio 367 
of 4.98, which is close to that of the present work (4.69) (Silva et al., 2008).  368 
In this work, the prepared nanoparticles were found to contain approximately 57% C, 369 
35% O, 4% N, 2% P and 1% S, the content of P being necessarily attributed to the 370 
cross-linking agent TPP, and that of S having origin in CRG. The obtained atomic 371 
percentages of C, O, N and P were comparable to those reported in other works for the 372 
analysis of CS/TPP nanoparticles (53.8% C, 33.8% O, 4.5% N and 2.7% P) (Calvo, 373 
Remuñan-López, Vila-Jato & Alonso, 1997b; Grenha, Seijo, Serra & Remuñán-López, 374 
2007). The slight variations can be explained by the use of CS of different 375 
characteristics and the analysis of nanoparticles with different compositions and mass 376 
ratios. The C/N ratio of nanoparticles assayed in the present study (14.3) is slightly 377 
higher than those reported by Grenha et al. (11.9)(Grenha, Seijo, Serra & Remuñán-378 
López, 2007) and Calvo et al. (10.9)(Calvo, Remuñan-López, Vila-Jato & Alonso, 379 
1997b). This difference is attributed to the presence of an extra compound in the 380 
nanoparticles formulation (CRG), which increased the amount of C, thereby increasing 381 
the C/N ratio.  382 
Unexpectedly, a certain amount of C and N were detected in the TPP and CRG 383 
samples, respectively. This effect was reported by other authors as corresponding to the 384 
atmospheric exposure of the samples, which led to the adsorption of some adventitious 385 
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carbon (Barr & Seal, 1995; Swift, 1982) and nitrogen (Allott, Curtis, Hall, Harriman & 386 
Battarbee, 1995; Baltrusaitis, Jayaweera & Grassian, 2009; Edwards, Zak, Kellner, 387 
Eisenlord & Pregitzer, 2011; Rao, Rao & Ppabhakaran, 1987) on the samples surface.  388 
In contrast to photoelectron spectroscopy techniques such as XPS, TOF-SIMS not 389 
only provides information on the elements present on analysed surfaces, but also offers 390 
detailed molecular information with high sensitivity. This technique has been useful in 391 
the characterization of surface chemistry of pharmaceutical systems (Barnes, Kempson 392 
& Prestidge, 2011). Figure 7 displays the negative mass spectra, between 50 and 110 393 
mass/u, obtained by TOF-SIMS for each of the analysed samples.  394 
The spectrum of CS (Figure 7A) evidences a peak at m/z 58 corresponding to 395 
C2H4NO (Al-Qadi, Grenha & Remuñán-López, 2011), as well as peaks at m/z 59 396 
(C2H3O2), 69 (C3HO2), and 71 (C3H3O2). Typical fragments of chitosan were also 397 
detected in the sample of control chitosan, such as C14H9NO, C4H21N14O and C8H15NO6 398 
(data not shown), the latter representing one of the typical units of chitosan molecule, 399 
N-acetyl-D-glucosamine (Grenha, Remunan-Lopez, Carvalho & Seijo, 2008; Grenha, 400 
Seijo, Serra & Remuñán-López, 2007). The CRG spectrum (Figure 7B) is dominated by 401 
SO2, SO3 and SO4H peaks, at m/z 64, 80 and 97, respectively. Smaller peaks, attributed 402 
to saccharide species, as well as to SO4, are also present. TPP spectrum (Figure 7C) 403 
consists of two peaks, corresponding to PO2 and PO3, at m/z 63 and 79 (Al-Qadi, 404 
Grenha & Remuñán-López, 2011). 405 
As it is demonstrated in Figure 7 C and D, the mass spectra of both nanoparticle 406 
formulations evidence peaks that are characteristic of all the previous spectra, which 407 
correspond to controls. The obtained results are in agreement with those previously 408 
observed in the XPS analysis, indicating the presence of all the components (CS, CRG 409 
and TPP) in the nanoparticles and suggesting a homogeneous distribution of the various 410 
18 
 
constituents through their matrix. However, given the novelty of this technique, few 411 
references were found reporting results of the application of TOF-SIMS on similar 412 
materials and those found report fragment peaks with higher masses (mass/u), thus, the 413 
establishment of comparisons with previously developed works was very scarce.  414 
 415 
4. Conclusions 416 
In this work, nanoparticles comprising CS, CRG and TPP were produced and 417 
characterized using several techniques such as photon correlation spectroscopy and laser 418 
Doppler anemometry, TEM, FTIR, XPS, and TOF-SIMS. The three components were 419 
identified in the FTIR, XPS and TOF-SIMS spectra of the nanoparticles, thus indicating 420 
an effective association of all the materials. In particular, their detection by the surface 421 
analysis techniques suggests a homogeneous distribution through the nanoparticles’ 422 
matrix. 423 
TPP acted as a cross-linker agent and, therefore, enabled the production of 424 
nanoparticles with smaller size, apart from increasing their production yield. In 425 
addition, the presence of TPP in the nanoparticle matrix increased their stability, 426 
providing a shelf-life of at least 9 months. Charge ratios were demonstrated to play a 427 
critical role in the nanoparticles formation, since a ratio around 1 leads to precipitation, 428 
owing to charge neutralization, while very high charge ratios do not provide enough 429 
charges to permit an interaction that induces nanoparticle formation. Overall, it was 430 
demonstrated that by modulating charge ratios, the final properties of CS/CRG/TPP 431 
nanoparticles can be adjusted to specific applications.  432 
Taking into account the small size and high positive charge displayed by the 433 
developed nanosystems, they are considered to hold potential for an application in 434 
mucosal delivery of macromolecules. 435 
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  575 
Table 1 - Surface composition (atomic percentage) determined by XPS of CS, CRG, TPP 
and CS/CRG/TPP nanoparticles of different ratios. 
 
 
Element CS (%) CRG (%) TPP (%) 4/1/1 NP (%) 5/1/1 NP (%) 
C 64.1 57.4 16.0 57.5 57.9 
O 29.6 38.2 63.6 35.2 35.1 
N 6.3 1.1 0 4.0 4.0 
P 0 0 20.4 2.0 1.7 
S 0 3.3 0 1.3 1.3 
Ratio O/N 4.69 35.7 0 8.75 8.73 
Ratio C/N 10.2 53.6 0 14.3 14.4 
CS: Chitosan, CRG: Carrageenan; NP: Nanoparticles; TPP: Tripolyphosphate 
Table 1
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Figure captions 576 
Fig. 1. Chemical structures of materials composing the matrix of nanoparticles: 577 
chitosan, k-carrageenan and sodium tripolyphosphate. 578 
Fig. 2. TEM microphotograph of representative CS/CRG/TPP (4/1/1) nanoparticles. 579 
Fig. 3. Representative scheme of A) positive/negative charge ratio of each formulation 580 
(white fill: formation of nanoparticles; dark grey: precipitation; light grey: inability to 581 
form nanoparticles); B) the ability to form nanoparticles according to formulation 582 
composition: precipitation (□); nanoparticles (●); solution (◊). 583 
Fig. 4. Effect of CS/CRG mass ratio and TPP amount on A) nanoparticle size (round 584 
marks) and zeta potential (triangular marks) and B) production yield of nanoparticle 585 
(square marks). White: 0 TPP; grey: 0.5 TPP; black: 1 TPP (mean ± SD, n = 3). 586 
Fig. 5. Evolution of CS/CRG (○) and CS/CRG/TPP (●) nanoparticle size as a function 587 
of time, upon storage at 4 ºC (mean ± SD, n = 3). 588 
Fig. 6. FTIR spectra of CS, CRG, TPP and CS/CRG/TPP (5/1/1) nanoparticles.  589 
Fig. 7. Negative ion mass spectra obtained by TOF-SIMS analysis of (A) CS, (B) CRG, 590 
(C) TPP, (D) CS/CRG/TPP = 4/1/1 nanoparticles and (E) CS/CRG/TPP = 5/1/1 591 
nanoparticles. 592 
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